
AXDX
Accelerate Diagnostics Inc
- Overview
- Forecast
- Valuation
- Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
27.15M
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
23.61M
EV
48.03M
EV/OCF(TTM)
--
P/S(TTM)
0.07
Accelerate Diagnostics, Inc. is an in-vitro diagnostics company. The Company is engaged in providing solutions that improve patient outcomes through the diagnosis of serious infections. Its in-vitro diagnostic platform, the Accelerate Pheno system utilizes genotypic technology to identify (ID), infectious pathogens and phenotypic technology to conduct antibiotic susceptibility testing (AST), which determines whether live bacterial or fungal cells are resistant or susceptible to a particular antibiotic. It detects and identifies pathogens directly from a single patient sample followed by antimicrobial susceptibility testing based on the identification results. The Accelerate Pheno system features walk-away automation and consists of a fixed instrument and single-use test kit. The Accelerate PhenoTest BC Kit, in conjunction with other clinical and laboratory findings, in the diagnosis of bacteremia and fungemia, both life-threatening conditions with high morbidity and mortality risk.
Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q3
FY2025Q2
FY2025Q1
3.10M
+4.2%
--
--
3.00M
+0.47%
--
--
3.00M
+2.7%
--
--
Estimates Revision
The market is revising No Change the revenue expectations for Accelerate Diagnostics, Inc. (AXDX) for FY2025, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by -94.11%.
Revenue Estimates for FY2025
No Change

0.00%
In Past 3 Month
Stock Price
Go Down

-94.11%
In Past 3 Month
Valuation Metrics
The current forward P/E ratio for Accelerate Diagnostics Inc (AXDX.O) is -0.04, compared to its 5-year average forward P/E of -6.39. For a more detailed relative valuation and DCF analysis to assess Accelerate Diagnostics Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A
5Y Average PE
-6.39
Current PE
-0.04
Overvalued PE
8.86
Undervalued PE
-21.65
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A
5Y Average EV/EBITDA
-4.53
Current EV/EBITDA
-1.35
Overvalued EV/EBITDA
1.16
Undervalued EV/EBITDA
-10.23
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

N/A
5Y Average PS
13.16
Current PS
0.27
Overvalued PS
27.24
Undervalued PS
-0.92
Financials
Annual
Quarterly
FY2024Q4
YoY :
-6.97%
2.82M
Total Revenue
FY2024Q4
YoY :
-26.08%
-7.93M
Operating Profit
FY2024Q4
YoY :
-26.23%
-9.59M
Net Income after Tax
FY2024Q4
YoY :
-57.30%
-0.38
EPS - Diluted
FY2024Q4
YoY :
-35.56%
-5.07M
Free Cash Flow
FY2024Q4
YoY :
-23.77%
15.94
Gross Profit Margin - %
FY2024Q4
YoY :
-38.24%
-211.17
FCF Margin - %
FY2024Q4
YoY :
-20.70%
-340.52
Net Margin - %
Trading Trends
Insider
Insiders areSelling! The selling amount has increased 3725.39% over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
22.9K
USD
4
6-9
Months
314.0K
USD
1
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
1
314.0K
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
0
0.0
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders areSelling! The selling amount has increased 3725.39% over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
22.9K
USD
4
6-9
Months
314.0K
USD
1
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
1
314.0K
USD
Months
0-12
0
0.0
USD
Months
AXDX News & Events
Events Timeline
2025-05-08 (ET)
2025-05-08
09:03:49
Accelerate Diagnostics files for Chapter 11 protection, agrees to sell assets

2025-04-15 (ET)
2025-04-15
17:42:50
Accelerate Diagnostics board forms committee to exlore strategic alternatives

2025-03-21 (ET)
2025-03-21
13:55:25
Accelerate Diagnostics submits WAVE system for FDA 510(k) clearance

Sign Up For More Events
Sign Up For More Events
News
4.5
05-14BenzingaNasdaq Gains Over 100 Points; Sony Group Posts Upbeat Earnings
9.5
05-14BenzingaWhy Everus Construction Group Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
4.5
05-13BenzingaUS Stocks Likely To Open Lower After A Strong Rally: 'Lows Are Likely In And Better Times Are Coming,' Says Expert
Sign Up For More News
People Also Watch

DAIO
Data I/O Corp
3.330
USD
-2.92%

CREX
Creative Realities Inc
2.920
USD
-1.02%

CTRM
Castor Maritime Inc
2.310
USD
-3.35%

IPW
iPower Inc
0.663
USD
+0.45%

DRRX
DURECT Corp
0.567
USD
-3.40%

MRKR
Marker Therapeutics Inc
1.560
USD
+4.00%

PGHL
Primega Group Holdings Ltd
0
USD
-22.59%

HYFM
Hydrofarm Holdings Group Inc
4.600
USD
+1.32%

XOS
Xos Inc
3.340
USD
-4.84%

IBIO
iBio Inc
0.733
USD
-0.95%
FAQ

What is Accelerate Diagnostics Inc (AXDX) stock price today?
The current price of AXDX is 0 USD — it has decreased -158.82 % in the last trading day.

What is Accelerate Diagnostics Inc (AXDX)'s business?

What is the price predicton of AXDX Stock?

What is Accelerate Diagnostics Inc (AXDX)'s revenue for the last quarter?

What is Accelerate Diagnostics Inc (AXDX)'s earnings per share (EPS) for the last quarter?

What changes have occurred in the market's expectations for Accelerate Diagnostics Inc (AXDX)'s fundamentals?

How many employees does Accelerate Diagnostics Inc (AXDX). have?
